SPECTRAL AI INC (MDAI)
US84757T1051 - Common Stock
Taking everything into account, MDAI scores 1 out of 10 in our fundamental rating. MDAI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. MDAI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MDAI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
MDAI had negative earnings in the past year.
In the past year MDAI has reported a negative cash flow from operations.
1.2 Ratios
MDAI has a Return On Assets of -95.84%. This is amonst the worse of the industry: MDAI underperforms 81.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -95.84% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)0.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MDAI has a Gross Margin of 45.34%. This is in the lower half of the industry: MDAI underperforms 62.57% of its industry peers.
The Profit Margin and Operating Margin are not available for MDAI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.34% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
MDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MDAI has been increased compared to 1 year ago.
Compared to 1 year ago, MDAI has a worse debt to assets ratio.
2.2 Solvency
MDAI has an Altman-Z score of -3.77. This is a bad value and indicates that MDAI is not financially healthy and even has some risk of bankruptcy.
MDAI has a worse Altman-Z score (-3.77) than 67.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.77 |
ROIC/WACCN/A
WACC9.17%
2.3 Liquidity
MDAI has a Current Ratio of 0.73. This is a bad value and indicates that MDAI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.73, MDAI is doing worse than 94.65% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that MDAI may have some problems paying its short term obligations.
The Quick ratio of MDAI (0.69) is worse than 92.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
MDAI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.82%.
MDAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 692.56%.
EPS 1Y (TTM)4.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.12%
Revenue 1Y (TTM)692.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%137.59%
3.2 Future
Based on estimates for the next years, MDAI will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.86% on average per year.
Based on estimates for the next years, MDAI will show a very strong growth in Revenue. The Revenue will grow by 39.70% on average per year.
EPS Next Y61.38%
EPS Next 2Y23.64%
EPS Next 3Y19.15%
EPS Next 5Y16.86%
Revenue Next Year59.11%
Revenue Next 2Y13.47%
Revenue Next 3Y29.89%
Revenue Next 5Y39.7%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
MDAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDAI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
MDAI's earnings are expected to grow with 19.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.64%
EPS Next 3Y19.15%
5. Dividend
5.1 Amount
MDAI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SPECTRAL AI INC
NASDAQ:MDAI (12/23/2024, 2:41:23 PM)
2.08
+0.19 (+10.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners15.89%
Inst Owner Change12.72%
Ins Owners41.92%
Ins Owner Change0%
Market Cap44.20M
Analysts84
Price Target5.71 (174.52%)
Short Float %29.02%
Short Ratio1.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.08%
Min EPS beat(2)-2.3%
Max EPS beat(2)52.47%
EPS beat(4)3
Avg EPS beat(4)20.12%
Min EPS beat(4)-2.3%
Max EPS beat(4)52.47%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.02%
Min Revenue beat(2)12.08%
Max Revenue beat(2)13.96%
Revenue beat(4)2
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-11.4%
Max Revenue beat(4)13.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)55.56%
EPS NY rev (1m)6.04%
EPS NY rev (3m)6.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.8%
Revenue NY rev (1m)1.98%
Revenue NY rev (3m)1.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.62 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS1.28
BVpS-0.2
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -95.84% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.34% | ||
| FCFM | N/A |
ROA(3y)0.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | -3.77 |
F-Score3
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.12%
EPS Next Y61.38%
EPS Next 2Y23.64%
EPS Next 3Y19.15%
EPS Next 5Y16.86%
Revenue 1Y (TTM)692.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%137.59%
Revenue Next Year59.11%
Revenue Next 2Y13.47%
Revenue Next 3Y29.89%
Revenue Next 5Y39.7%
EBIT growth 1Y-29.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.92%
EBIT Next 3Y25.02%
EBIT Next 5Y23.2%
FCF growth 1Y-1620.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1620.43%
OCF growth 3YN/A
OCF growth 5YN/A